FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer.

Yan, Xiuchun; Dai, Junzhu; Han, Ying; You, Qi; Liu, Yao

Yan, Xiuchun; Dai, Junzhu; Han, Ying; You, Qi; Liu, Yao.

Afiliação

Yan X; Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China.
Dai J; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Han Y; Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China.
You Q; Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150081, China.
Liu Y; Department of Cancer Prevention and Physical Examination Center, Harbin Medical University Cancer Hospital, Harbin 150081, China.

Dis Markers ; 2022: 2478551, 2022.

Article em En | MEDLINE | ID: mdl-35692888

Assuntos

Neoplasias Gástricas; Proteínas de Transporte/genética; Humanos; Imuno-Histoquímica; Prognóstico; RNA Mensageiro/genética; RNA Mensageiro/metabolismo; Estudos Retrospectivos; Proteínas de Plasma Seminal/genética; Proteínas de Plasma Seminal/metabolismo; Neoplasias Gástricas/patologia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Dis Markers Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google